Clinical Governance Audit at Organisational Boundaries
Every existing assurance framework measures governance within organisations. None measures what happens between them. The Boundary Risk Assessment makes boundary governance visible, scored, and actionable.
A Boundary Risk Assessment is a clinical governance audit of patient safety, data governance, and clinical responsibility transfer at the joins between healthcare organisations. It scores every organisational boundary across seven governance dimensions, identifies cross-organisational risks that no internal framework measures, and produces a funded remediation roadmap.
CQC Well-Led, DCB 0129/0160, PSIRF, DSPT — each assesses governance within an organisation. None assesses what happens between them. That's where patients are most vulnerable, where data governance is weakest, and where clinical responsibility falls into gaps. A CQC 'Requires Improvement' rating often traces back to ungoverned boundaries, not internal process failures.
For the first time, your board gets a scored, per-boundary view of governance maturity — with statutory traceability, cascading failure logic, and a funded remediation roadmap. Think of it as a mock CQC inspection for the spaces between organisations.
The cost of not knowing: A single delayed discharge investigation can exceed six figures. CQC enforcement action following a boundary failure triggers independent review costs, reputational damage, and board-level distraction. A safeguarding serious case review involving cross-organisational gaps is even more costly. The Boundary Risk Assessment costs a fraction of any one of these.
Trusted by organisations operating across: NHS & Private Pathways · Multi-Provider Networks · Healthcare Investors & Acquirers · Clinical Safety & Digital Governance Leaders
Why Care Transitions Fail at the Boundary
70.1% of 14,747 NHS digital health deployments have no documented clinical safety assurance.
Source: JMIR, 2025
PSIRF "does not create a wider policy environment for cross-boundary arrangements that promote cross-system patient safety."
Source: Journal of Long-Term Care, 2025
ICBs are unable to coordinate cross-organisational safety investigations in practice.
Source: HSSIB, October 2025
These findings describe governance within organisations. The boundary dimension — where systems, data, and responsibility cross between organisations — represents the most significant healthcare interoperability risk that remains entirely unassessed. Our assessment doesn’t just look at data; it evaluates the governance of care transitions, ensuring that clinical responsibility doesn’t dissolve as a patient moves from a hospital ward to a community setting.
Typical triggers for a Boundary Risk Assessment
Most organisations recognise boundary risk when a specific event forces visibility. These are the situations that typically bring organisations to a Boundary Risk Assessment.
Post-acquisition integration
Two governance frameworks that must work together but were designed independently.
Preparing for CQC inspection
Internal governance is strong but boundary governance has never been formally assessed. A mock CQC inspection won't catch what happens between you and your partners.
Clinical incident at a boundary
A patient safety event that neither organisation's internal processes detected or prevented.
New provider partnership
Establishing referral pathways, data sharing agreements, or sub-contracting arrangements.
Healthcare due diligence (M&A)
Commercial Due Diligence (CDD) for healthcare acquisitions. Investors requiring governance assurance across portfolio boundaries before or after acquisition.
ICS or provider collaboration
Standing up cross-organisational models that need proactive governance design from day one.
NHS-private referral pathways
Designing referral routes that cross constitutional domains — from NHS to private or insurer to care.
Board assurance requirement
Board requesting evidence that boundary-specific risks are identified, assessed, and managed.
Assuring Care Transitions: A Three-Pillar Assessment
Seven Flows Methodology
Every boundary scored across seven governance dimensions: Identity, Consent, Provenance, Clinical Intent, Alert & Responsibility, Service Routing, and Outcome. Cascading failure logic reveals structural dependencies invisible to internal governance.
How Seven Flows works →Constitutional Transition Analysis
Not all boundaries are equal. When data crosses from NHS to private, or from care to insurance, the legislation changes, the regulator changes, and the institutional orientation towards the patient changes. Our Constitutional Transition Matrix maps every domain crossing and rates the additional governance risk.
See the constitutional domains →Infrastructure & Funded Remediation
Can your technology enforce governance programmatically? Our technology assessment evaluates each boundary's infrastructure and produces a vendor-neutral remediation roadmap — with a funded business case using available cloud migration incentives.
How the technology assessment works →Offset audit costs with cloud funding. Many organisations can part-fund their Boundary Risk Assessment through available cloud migration and digital transformation incentives. Ask us how →
From scoping call to Boundary Risk Score
Scope
60-minute call. We identify your organisational boundaries, constitutional crossings, and priority flows. You tell us where you think the risk is. We tell you where we've seen it before.
Assess
Structured interviews on both sides of every boundary. Six stakeholder roles. Three-level evidence hierarchy: Documentary, Demonstrable, Observed. Cross-organisation evidence reconciliation.
Score
Per-boundary, per-flow maturity rating (0–4). Raw and cascade-adjusted scores. Constitutional Transition Analysis. MVRT compliance evaluation. Technology readiness assessment.
Report
Board-ready scorecard. Legal traceability matrix. Funded remediation roadmap. Executive presentation. Every finding mapped to CQC, DCB, UK GDPR, and PSIRF obligations.
What your board receives
The Boundary Risk Score gives your board a single, defensible metric for governance at every organisational boundary. Here's what it looks like.
| Flow | Raw Score | Cascade-Adjusted | Key Finding |
|---|---|---|---|
| Identity | 2 | 2 | PDS lookup at discharge, no verification at GP receipt |
| Consent | 2 | 2 | Generic DSA, no boundary-specific DPIA |
| Provenance | 1 | 1 | Author identified but no structured metadata |
| Clinical Intent | 1 | 1 | Free-text discharge, no structured action codes |
| Alert & Responsibility | 1 | 1 | MVRT failure: discharge completes without confirmed GP receipt |
| Service Routing | 2 | 1 | Cascade-adjusted: Clinical Intent < 2 caps routing |
| Outcome | 1 | 1 | No structured outcome feedback across boundary |
- Per-boundary, per-flow scoring (0–4 maturity scale)
- Raw and cascade-adjusted scores showing structural dependencies
- MVRT compliance assessment at every boundary
- Overall rating: Assured / Conditional / Not Assured
- Every finding mapped to specific statutory obligations
Built for the people who own boundary risk
Private Healthcare Groups
Post-acquisition integration. Provider network governance. CQC readiness at organisational boundaries. NHS sub-contracting compliance.
Boundary governance for private healthcare →Clinical Safety Officers
Boundary-specific hazard identification. Cross-organisation evidence reconciliation. DCB 0129/0160 extended to boundaries. Evidence for your hazard log.
CSO-specific boundary risk guidance →PE Firms & Acquirers
Commercial Due Diligence (CDD) for healthcare M&A. Pre-acquisition boundary mapping. Constitutional Transition Analysis as a risk pricing tool. Portfolio-level Boundary Risk Score. Post-acquisition governance roadmap.
Healthcare due diligence framework →Insurers & PMI Networks
Provider network governance. Pre-authorisation boundary assessment. Constitutional crossing analysis. Claims pathway governance.
Discuss insurer boundary governance →ICB & Place Leaders
Assessing the safety of integrated care transitions between NHS Trusts and Local Authority social care providers to reduce delayed discharges and safeguarding gaps.
Neighbourhood health governance →Engagement tiers
Boundary Risk Snapshot
2–4 weeks · 2–3 boundaries
- Scorecard with per-boundary, per-flow scoring
- Priority remediation recommendations
- Executive summary
Boundary Governance Audit
6–10 weeks · 4–8 boundaries
- Full scorecard with cascade adjustments
- Legal traceability matrix
- Technology assessment
- Funded remediation roadmap
Boundary Governance Programme
10–16 weeks · 8+ boundaries or system-wide
- All audit deliverables
- Funded business case
- Board presentation
- Quarterly review option
Pricing is modelled on the number of boundaries and the complexity of each boundary or ongoing pathway. We scope every engagement individually so you pay for what matters.
A Boundary Risk Snapshot takes 2–4 weeks. A full Boundary Governance Audit takes 6–10 weeks. A Boundary Governance Programme for complex or multi-site organisations takes 10–16 weeks.
No. The assessment is based on structured interviews, document review, and observed processes. We don't require access to your IT systems, patient data, or clinical records. We assess governance control maturity at boundaries — the processes, documentation, and organisational arrangements that govern how data and responsibility cross between organisations.
Yes. Many organisations start with a Boundary Risk Snapshot focused on their highest-risk boundary, then expand to a full Audit once they've seen the methodology and output. The scoring framework is consistent across tiers, so Snapshot scores carry forward into broader assessments.
A DCB 0129 gap analysis evaluates how well an organisation complies with the NHS clinical risk management standard for health IT systems. The Boundary Risk Assessment extends this to the boundary dimension — assessing not just whether your internal systems meet DCB 0129, but whether clinical safety is maintained when data and responsibility cross between your organisation and your partners.
A mock CQC inspection assesses governance within a single organisation. The Boundary Risk Assessment extends that rigour to the spaces between organisations — the handovers, data flows, and responsibility transfers that CQC's Well-Led framework expects you to govern but doesn't specifically inspect. Many organisations use the Boundary Risk Assessment alongside a mock CQC inspection to ensure their boundary governance is as strong as their internal governance.
Commercial Due Diligence (CDD) in healthcare assesses the operational, regulatory, and governance risks of a target acquisition. The Boundary Risk Assessment provides the governance component: a scored, per-boundary evaluation of how clinical responsibility, data, and patient safety are managed across the target's organisational boundaries. PE firms and hospital group acquirers use it to price boundary risk before completion and design post-acquisition governance roadmaps.
Independent. Vendor-neutral. Statutory-traceable.
The Boundary Risk Assessment is a diagnostic engagement. It evaluates governance requirements — it does not prescribe specific vendors, platforms, or implementation approaches. The technology assessment specifies what any compliant solution must do, not which solution to buy. If you engage us for remediation, that's a separate engagement with separate terms. You're free to use any implementation partner.
The assessment does not certify clinical safety outcomes. It does not transfer statutory responsibility from your CSO, Registered Manager, or provider. It provides evidence that assists your organisation in understanding and meeting its boundary-specific obligations.
